EP2101749A4 - Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof - Google Patents
Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereofInfo
- Publication number
- EP2101749A4 EP2101749A4 EP06824120A EP06824120A EP2101749A4 EP 2101749 A4 EP2101749 A4 EP 2101749A4 EP 06824120 A EP06824120 A EP 06824120A EP 06824120 A EP06824120 A EP 06824120A EP 2101749 A4 EP2101749 A4 EP 2101749A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treating
- pharmaceutical composition
- diabetes mellitus
- preventing diabetes
- lithospermum erythrorhizon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2006/005414 WO2008072799A1 (en) | 2006-12-12 | 2006-12-12 | Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2101749A1 EP2101749A1 (en) | 2009-09-23 |
EP2101749A4 true EP2101749A4 (en) | 2010-04-21 |
Family
ID=39511797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06824120A Withdrawn EP2101749A4 (en) | 2006-12-12 | 2006-12-12 | Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100093852A1 (en) |
EP (1) | EP2101749A4 (en) |
JP (1) | JP2010512382A (en) |
CN (1) | CN101646428A (en) |
CA (1) | CA2678524A1 (en) |
WO (1) | WO2008072799A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103130680A (en) * | 2013-02-04 | 2013-06-05 | 上海交通大学 | High-optical-purity alkannin and Akannin naphthazarin nuclear parent hydroxyl methylation carbonyl oxime derivative and preparation method and application thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526016A (en) * | 2012-02-17 | 2012-07-04 | 中山大学 | Application of 5,8-dyhydroxyl-2-(1-acetyl-4-methyl-3-pentenyl)-1,4-naphthoquinone diketone to preparation of medicines for resisting diabetes |
JP6322784B2 (en) * | 2013-03-29 | 2018-05-16 | 株式会社大阪ソーダ | Method for producing complex of shikonin compound and β-1,3-1,6-glucan |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006011394A1 (en) * | 2004-07-30 | 2006-02-02 | Japan Health Sciences Foundation | Antiprotozoal agent |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10212230A (en) * | 1997-01-29 | 1998-08-11 | Kureha Chem Ind Co Ltd | Inhibitor containing dihydroxynaphthoquinone to inhibit synthesis of protein belonging to hsp60 family |
TW200513257A (en) * | 2003-06-20 | 2005-04-16 | Takara Bio Inc | Extract from parsley and preparation thereof |
-
2006
- 2006-12-12 EP EP06824120A patent/EP2101749A4/en not_active Withdrawn
- 2006-12-12 CA CA002678524A patent/CA2678524A1/en not_active Abandoned
- 2006-12-12 WO PCT/KR2006/005414 patent/WO2008072799A1/en active Application Filing
- 2006-12-12 CN CN200680056611A patent/CN101646428A/en active Pending
- 2006-12-12 US US12/312,943 patent/US20100093852A1/en not_active Abandoned
- 2006-12-12 JP JP2009541203A patent/JP2010512382A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006011394A1 (en) * | 2004-07-30 | 2006-02-02 | Japan Health Sciences Foundation | Antiprotozoal agent |
EP1779892A1 (en) * | 2004-07-30 | 2007-05-02 | Japan Health Sciences Foundation | Antiprotozoal agent |
Non-Patent Citations (1)
Title |
---|
See also references of WO2008072799A1 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103130680A (en) * | 2013-02-04 | 2013-06-05 | 上海交通大学 | High-optical-purity alkannin and Akannin naphthazarin nuclear parent hydroxyl methylation carbonyl oxime derivative and preparation method and application thereof |
CN103130680B (en) * | 2013-02-04 | 2014-12-10 | 上海交通大学 | High-optical-purity alkannin and Akannin naphthazarin nuclear parent hydroxyl methylation carbonyl oxime derivative and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101646428A (en) | 2010-02-10 |
CA2678524A1 (en) | 2008-06-19 |
US20100093852A1 (en) | 2010-04-15 |
EP2101749A1 (en) | 2009-09-23 |
WO2008072799A1 (en) | 2008-06-19 |
JP2010512382A (en) | 2010-04-22 |
WO2008072799A9 (en) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL186303A (en) | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position, pharmaceutical compositions comprising same and use thereof for preparation of a medicament for treating cancer | |
IL204440A (en) | Pharmaceutical compositions comprising thiazolidinedione analogues for use in treating diabetes | |
IL181304A (en) | Use of dihydropteridinones for the preparation of a pharmaceutical composition for treating myelodysplastic syndrome | |
IL225198A (en) | Aminotetrahydropyran compounds, pharmaceutical compositions comprising the same and the use thereof for the treatment of diabetes | |
EP2070540A4 (en) | Drug composition for treating 2 type diabetes and its chronicity neopathy | |
EP1817008A4 (en) | Stabilized hme composition with small drug particles | |
IL185761A0 (en) | Pharmaceutical compositions for treating diabetes | |
IL195947A (en) | Fused cyclic compounds and pharmaceutical compositions comprising them for use in the prevention and treatment of diabetes | |
IL185277A0 (en) | Pharmaceutical compositions containing roflumilast for the treatment of diabetes | |
CL2007003614A1 (en) | COMPOUNDS DERIVED FROM SULFONIL-FENIL-2H- [1,2,4] OXADIAZOL-5-ONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; PREPARATION PROCEDURE; AND USE OF THE COMPOUND IN THE TREATMENT OF METABOLISM DISORDERS, AS DIABETES MELLITUS, DIS | |
EP2048153A4 (en) | Substituted spiroketal derivative and use thereof as drug for treating diabetes | |
EP1991218A4 (en) | Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives | |
GB2434604B (en) | Porous composites containing hydrocarbon-soluble well treatment agents and methods for using the same | |
EP1982724A4 (en) | Therapeutic agent for metabolic syndrome and food containing the therapeutic agent | |
EP2199295A4 (en) | Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome | |
EP2030612A4 (en) | Pharmaceutical composition for treating burns (variants) and a method for the production thereof (variants) | |
IL177609A (en) | Use of gabaculine or its analog in the manufacture of a medicament for treating hepatocellular carcinoma | |
IL196561A (en) | Use of sulfamide and glinide atp-sensitive potassium channel ligands for the preparation of pharmaceutical compositions for treating diabetes mellitus and/or neuropsychological disorders | |
EP2059503A4 (en) | Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same | |
EP1968559A4 (en) | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes | |
EP2101749A4 (en) | Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof | |
EP2231146A4 (en) | Pharmaceutical composition for the treatment and prevention of glaucoma | |
EP2193789A4 (en) | The application of 3, 5-dihydroxytoluene or derivatives thereof in the preparation of medicine and functional for treating or preventing depression. | |
EP2005964A4 (en) | The medicament for treating hyperphospheremia and preparation thereof | |
ZA200806949B (en) | Medicinal formulation for the treatment for hepatitis C |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090612 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: PARK, JI HO Inventor name: KANG, CHUL HOON Inventor name: HWANG, EUN JU Inventor name: KIM, SUN YEOU Inventor name: KANG, TONG HO |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100322 |
|
17Q | First examination report despatched |
Effective date: 20100517 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20120705 |